HopeStage
Back to all studies
RecruitingNCT06054321

Biomarker-guided medication strategies compared with antidepressant treatment alone

About this titleRead the official source — NCT06054321
Medication studyAges 19–65South KoreaDepression
The study in practice

Understand this study

Who could participate?

Listed age limits: 19 years to 65 years.

What will I do during this study?

Your assigned group receives either escitalopram alone or a stepwise medication strategy that can involve adding another medication. The protocol calls for treatment decisions or dose increases to be reviewed every three weeks.

Listed locations
GwangjuSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: August 3, 2022
Recruitment status
Recruiting
Enrollment listed in the registry
400
Sponsor
Chonnam National University Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Locations
South Korea
Age range
From 19 Years to 65 Years
Official registry ID
NCT06054321
Official title
Show the full official title

A Randomized Clinical Trial of Response to Psychopharmacotherapy According to Multimodal Serum Biomarkers in Depressive Patients

Recruitment & locations

Currently recruiting

Gwangju

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Chonnam National University Hospital, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including stepwise pharmacotherapy and antidepressant monotherapy group.

Who can participate?

Listed age limits: 19 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies